Learning Objectives:
Define the clinical definition of HFrEF, HFmidREF, and HFpEF
Describe the current epidemiology, economic burden, and quality standards
Explain the underlying pathophysiology of HFrEF and HFpEF with associated signs and symptoms
Speakers:
Ajith P. Nair, MD, FACC, FAHA, Assistant Professor, Cardiology, Baylor College of Medicine
Nikolaos A. Diakos, MD, PhD, Interventional Cardiologist and Heart Failure Specialist, Texas Heart Institute
Panelists:
Jessica Brown, MD, Cardiology and Heart Failure Specialist, Baylor St. Luke's Medical Group Woodlands North Houston Heart Center
Moderator:
John A. Flynn, MD, MBA, MEd, System Senior Vice President, Physician Enterprise, CommonSpirit Health, Texas
4 окт 2024